01 4GlaxoSmithKline Inc.
01 22350073
02 22408909
01 4Maraviroc
01 4Tablet
01 22019-12-23
02 22021-05-09
Patent Expiration Date : 2019-12-23
Date Granted : 2007-04-17
Brand Name : CELSENTRI
Patent Number : 2350073
Filing Date : 1999-12-23
Strength per Unit : 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-23
Date Granted : 2007-04-17
Patent Expiration Date : 2021-05-09
Date Granted : 2006-06-27
Brand Name : CELSENTRI
Patent Number : 2408909
Filing Date : 2001-05-09
Strength per Unit : 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-05-09
Date Granted : 2006-06-27
Patent Expiration Date : 2021-05-09
Date Granted : 2006-06-27
Brand Name : CELSENTRI
Patent Number : 2408909
Filing Date : 2001-05-09
Strength per Unit : 150mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-05-09
Date Granted : 2006-06-27
Patent Expiration Date : 2019-12-23
Date Granted : 2007-04-17
Brand Name : CELSENTRI
Patent Number : 2350073
Filing Date : 1999-12-23
Strength per Unit : 150mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-23
Date Granted : 2007-04-17
LOOKING FOR A SUPPLIER?
